💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Stocks slip on Japan fiscal stimulus approval, yen rallies

Published 08/02/2016, 11:54 AM
© Reuters. Passersby are reflected on a stock quotation board outside a brokerage in Tokyo, Japan
XAU/USD
-
US500
-
DJI
-
SOGN
-
PFE
-
DX
-
GC
-
LCO
-
CL
-
IXIC
-

By Saqib Iqbal Ahmed

NEW YORK (Reuters) - Wall Street stocks opened lower on Tuesday after weak U.S. economic data disappointed investors, further dragging on global equity prices after the approval of a fiscal stimulus package by Japan's cabinet failed to cheer markets.

Oil rebounded strongly after having fallen as much as 10 percent in one week, but concerns about oversupply lingered.

Japanese Prime Minister Shinzo Abe's cabinet approved 13.5 trillion yen ($132 billion) in fiscal measures on Tuesday. The easing moves were perceived as less aggressive than anticipated and the yen rallied to a three-week high against the U.S. dollar.

"There's quite a lot of skepticism in the market as to whether this fiscal package can change anything," said Alvin Tan, a strategist at Societe Generale (PA:SOGN).

Last week, the Bank of Japan announced easing steps that disappointed investors who had hoped for more.

"These governments are flailing about looking for something that will get it back on track, and certainly public confidence that they have really done enough has been something that has been difficult to achieve," said Bruce McCain, chief investment strategist at Key Private Bank in Cleveland.

MSCI's world stocks index, which tracks shares in 45 nations, was down 0.75 percent.

Wall Street added to Monday's modest losses after data showed inflation still muted and below the U.S. Federal Reserve's 2 percent target, despite a better-than-expected rise in consumer spending in June.

The Dow Jones industrial average fell 111.97 points, or 0.61 percent, to 18,292.54, the S&P 500 lost 16.99 points, or 0.78 percent, to 2,153.85 and the Nasdaq Composite dropped 53.84 points, or 1.04 percent, to 5,130.36.

Dow component Pfizer (NYSE:PFE) was one of the biggest drags on the S&P 500 after revenue from its array of branded patent-protected medicines disappointed investors.

European stocks dropped to a three-week low, dragged down by banks, after Commerzbank's shares slid to a record low after the bank warned that its earnings would fall this year.

Oil rose more than 2 percent in early trading after falling by around $4 a barrel in one week. But investors remained concerned about oversupply weighing on prices, which subsequently turned lower.

Brent crude was off 1 percent at $41.72 a barrel, while U.S. crude fell 1.5 percent to $39.48.

The U.S. dollar dropped to a six-week low against a basket of currencies, pressured by expectations that the Federal Reserve would delay raising interest rates after the recent soft U.S. economic data. The dollar index was down 0.64 percent at 95.096.

In bond trading, U.S. Treasury yields surged on the Japanese fiscal stimulus measures, dampening demand for U.S. government debt and sending long-dated U.S. yields to their highest levels in more than a week.

U.S. 30-year yields rose the most among U.S. Treasuries and hit 2.332 percent, their highest since July 21, as prices fell more than two full points. Benchmark 10-year yields hit a six-day high of 1.573 percent.

© Reuters. Passersby are reflected on a stock quotation board outside a brokerage in Tokyo, Japan

Spot gold prices were up 1 percent to $1,366.35an ounce.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.